An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells

Clinical and Experimental Metastasis

Volumn 15, Issue 5, 1997, Pages 469-483

  Jang, A ^a   Hill, R P ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Metastasis; Metastasis associated genes; Microenvironmental stress; Murine tumor cells

Indexed keywords

CATHEPSIN B; CATHEPSIN L; GELATINASE A; GELATINASE B; MESSENGER RNA; OSTEOPONTIN; TISSUE INHIBITOR OF METALLOPROTEINASE; VASCULOTROPIN;

ACIDOSIS; ANIMAL CELL; ARTICLE; CELL GROWTH; CELL HYPOXIA; ENVIRONMENTAL FACTOR; ENZYME SYNTHESIS; FIBROSARCOMA; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; SQUAMOUS CELL CARCINOMA; STRESS; TUMOR CELL CULTURE;

ACIDOSIS; ANIMALS; ANOXIA; BLOTTING, NORTHERN; CARCINOMA, SQUAMOUS CELL; CATHEPSIN B; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOPEPTIDASES; ENDOTHELIAL GROWTH FACTORS; FIBROSARCOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE; GLYCOPROTEINS; LYMPHOKINES; MELANOMA; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; NEOPLASM METASTASIS; OSTEOPONTIN; SIALOGLYCOPROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030873998     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018470709523     Document Type: Article

References (84)

1. Schlappack OK, Zimmermann A and Hill RP, 1991, Glucose starvation and acidosis: effect on experimental metastatic potential, DNA content and MTX resistance of murine tumor cells. Br J Cancer, 64, 663-70.
2. Young SD Marshall RS and Hill RP, 1988, Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci USA, 85, 9533-7.
3. Young SD and Hill RP, 1990, Effects of reoxygenation of cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential. J Natl Cancer Inst, 82, 371-80.
4. Young SD and Hill RP, 1990, Effects of reoxygenation on cells from hypoxic regions of solid tumors: analysis of transplanted murine tumors for evidence of DNA overreplication. Cancer Res, 50, 5031-8.
5. Stackpole CW, Groszek L and Kalbag SS, 1994, Benign-to-malignant B16 melanoma progression induced in two stages in vitro by exposure to hypoxia. J Natl Cancer Inst, 86, 361-7.
6. Brizel DM, Scully SP, Harrelson JM, et al. 1996, Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res, 56, 941-3.
7. Höckel M, Schlenger K, Mitze M, et al. 1996, Hypoxia and radiation response in human tumors. Sem Radiat Oncol, 6, 3-9.
8. Graeber TG, Osmanian C, Jacks T, et al. 1996, Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature, 379, 88-91.
9. Kato Y, Nakayama Y, Umeda M, et al. 1992, Induction of 103-kDa gelatinase/Type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines. J Biol Chem, 267, 11424-30.
10. Martínez-Zaguilán R, Seftor E A, Sefter RE, et al. 1996, Acidic pH enhances the invasive behaviour of human melanoma cells. Clin Exp Metastasis, 14, 176-86.
11. Young SD and Hill RP, 1986, Dynamic heterogeneity: isolation of murine tumor cell populations enriched for metastatic variants and quantification of the unstable expression of the phenotype. Clin Exp Metastasis, 4, 153-76.
12. Gingras MC, Finch LJJ, Bowden GT, et al. 1990, Transient alterations in the expression of protease and extracellular matrix genes during metastatic lung colonization by H-ras-transformed 10T1/2 fibroblasts. Cancer Res, 50, 4061-6.
13. Anderson GA, Stoler DL and Scacello LA, 1989, Normal fibroblasts responding to anoxia exhibit features of the malignant phenotype. J Biol Chem, 264, 14885-92.
14. Shweiki D, Itin A, Soffer D, et al. 1992, Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature, 359, 843-5.
15. Shweiki D, Neeman M, Itin A, et al. 1995, Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis. Proc Natl Acad Sci USA, 92, 768-72.
16. Potgens AJG, Westphal HR, de Waal RMW, et al. 1995, The role of vascular permeability factor and basic fibroblast growth factor in tumor angiogenesis. Biol Chem Hoppe-Seyler, 376, 57-70.
17. Senger DR, Van De Water L, Brown LF, et al. 1993, Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Met Rev, 12, 303-24.
18. Gitay-Goren H, Halaban R and Neufeld G, 1993, Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors. Biochem Biophvs Res Commun, 190, 702-9.
19. Takahashi Y, Kitadai Y, Bucana CD, et al. 1995, Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res, 55, 3964-8.
20. Warren RS, Yuan H, Matli MR, et al. 1995, Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest, 95, 1789-97.
21. Kieser A, Weich HA, Brandner G, et al. 1994, Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene, 9, 963-9.
22. Mukhopadhyay D, Tsiokas L, Zhou X-M, et al. 1995, Hypoxia induction of human vascular endothelial growth factor expression through c-src activation. Nature, 375, 577-81.
23. Mukhopadhyay D, Tsiokas L and Sukhatme VP, 1995, Wild-type p53 and v-src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res, 55, 6161-5.
24. Rak J, Mitsuhashi Y, Bayko L, et al. 1995, Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res, 55, 4575-80.
25. Unemori EN, Ferrara N, Baure EA, et al. 1992, Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol, 153, 557-62.
26. Mandriota SJ, Seghezzi G, Vassalli J-D, et al. 1995, Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem, 270, 9709-16.
27. Hart IR and Fidler IJ, 1981, The implications of tumor heterogeneity for studies on the biology and therapy of cancer metastasis. Biochim Biophys Acta, 651, 37-50.
28. r 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res, 50, 3872-77.
29. Bernhard EJ, Gruber SB, and Muschel, RJ, 1994, Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci USA, 91, 4293-97.
30. Brown PD, Bloxidge RE, Stuart NSA, et al. 1993, Association between expression of activated 72-kilo-dalton gelatinase and tumor spread in non-small cell lung carcinoma. J Natl Cancer Inst, 85, 574-78.
31. Brown PD, Bloxidge RE, Anderson E, et al. 1993, Expression of activated gelatinase in human invasive breast carcinoma. Clin Exp Metastasis, 11, 183-89.
32. Davies B, Waxman J, Wasan H, et al. 1993, Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res, 53, 5365-9.
33. Davies B, Miles DW, Happerfield LC, et al. 1993, Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer, 67, 1126-31.
34. DeClerck YA, Perez N, Shimada H, et al. 1992, Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res, 52, 701-8.
35. Khokha R, Zimmer MJ, Graham CH, et al. 1992, Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J Natl Cancer Inst, 84, 1017-22.
36. Khokha R, Zimmer MJ, Wilson SM, et al. 1992, Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo. Clin Exp Metastasis, 10, 365-70.
37. Khokha R, 1994, Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of metalloproteinases-1. J Natl Cancer Inst, 86, 299-304.
38. Chambers AF, Colella R, Denhardt DT, et al. 1992, Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, rastransformed NIH 3T3 cells. Mol Carcin, 5, 238-45.
39. Denhardt DT, Greenberg AH, Egan SE, et al. 1987, Cysteine proteinase cathepsin L expression cerrelated closely with the metastatic potential of H-ras-transformed murine fibroblasts. Oncogene, 2, 55-9.
40. Sloane BF, Moin K, Krepela E, et al. 1990, Cathepsin B and its endogenous inhibitors: the role in tumor malignancy. Cancer and Metastasis Rev, 9, 333-52.
41. Steeg PS, Bevilacqua G, Kopper L, et al. 1988, Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst, 80, 200-4.
42. Steeg PS and Liotta LA, 1990, Reduced nm23 expression in tumor metastasis. Proc Am Assoc Cancer Res, 31, 504-5.
43. Rosengard AM, Krutzsch HC, Shearn A, et al. 1989, Reduced nm23/awd protein in tumor metastasis and aberrant Drosophila development. Nature, 342, 177-80.
44. MacDonald NJ, De La Rosa A and Steeg PS, 1995, The potential roles of nm23 in cancer metastasis and cellular differentiation. Eur J Cancer, 31A, 1096-100.
45. Cuvier C, Jang A and Hill RP, 1997, Exposure to hypoxia, glucose starvation, and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L+B) secretion. Clin Exp Metastasis, 15, 19-25.
46. Chomczynski P and Sacchi N, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem, 162, 156-9.
47. Bhatia P, Taylor WR, Greenberg AH, et al. 1994, Comparison of glyceraldehyde-3-phosphate dehydrogenase and 28S-ribosomal RNA gene expression as RNA loading controls for northern blot analysis of cell lines with varying metastatic potential. Anal Biochem, 216, 223-6.
48. Herron GS, Banda MJ, Clark EJ, et al. 1986, Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J Biol Chem, 261, 2814-18.
49. Qian F, Bajkowski AS, Steiner DF, et al. 1989, Expression of live cathepsins in murine melanomas of varying metastatic potential and normal tissues. Cancer Res, 49, 4870-5.
50. Craig AM, Bowden GT, Chambers AF, et al. 1990, Secreted phosphoprotein mRNA is induced during multi-stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblasts. Int J Cancer, 46, 133-7.
51. 5. J Biol Chem, 270, 26232-8.
52. 3 integrin stimulates immediate cell signals in osteoclasts. J Biol Chem, 266, 20369-74.
53. Moin K, Rozhin J, McKernan TB, et al. 1989, Enhanced levels of cathepsin B mRNA in murine tumors. FEBS Lett, 244, 61-4.
54. Rozhin J, Gomez AP, Ziegler GH, et al. 1990, Cathepsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulations isolated from murine tumors. Cancer Res, 50, 6278-84.
55. Sloane BF, Rozhin J, Moin K, et al. 1992, Cysteine endopeptidases and their inhibitors in malignant progression of rat embryo fibroblasts. Biol Chem Hoppe-Seyler, 373, 589-94.
56. Sloane BF, Rozhin J, Krepela E, et al. 1991, The malignant phenotype and cysteine proteinases. Biomed Biochim Acta, 50, 549-54.
57. Liotta LA and Stetler-Stevenson WG, 1991, Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res (suppl), 51, 5054s-5059s.
58. Lokeshwar BL, Selzer MG, Block NL, et al. 1993, Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues. Cancer Res, 53, 4493-8.
59. Denhardt DT and Guo X, 1993, Osteopontin: a protein with diverse functions. FASEB J, 7, 1475-82.
60. Feng B, Rollo EE and Denhardt DT, 1995, Osteopontin (OPN) may facilitate metastasis by protecting cells from macrophage NO-mediated cytotoxicity: evidence from cell lines down-regulated for OPN expression by a targeted ribozyme. Clin Exp Metastasis, 13, 453-62.
61. Behrend EI, Craig AM, Wilson SM, et al. 1994, Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Cancer Res, 54, 823-37.
62. Chambers AF, Behrend EI, Wilson SM, et al. 1992, Induction of expression of Osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells. Anticancer Res, 12, 43-8.
63. Leone A, Flatow LJ, King CR, et al. 1991, Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell, 65, 25-35.
64. Parhar RS, Shi Y, Zou M, et al. 1995, Effects of cytokine-mediated modulation of nm23 expression on the invasion and metastatic behavior of B16F10 melanoma cells. Int J Cancer, 60, 204-10.
65. Minchenko A, Bauer T, Salceda S, et al. 1994, Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest, 71, 374-9.
66. Saiki I, Murata J, Yoneda J, et al. 1994, Influence of fibroblasts on the invasion and migration of highly or weakly metastatic B16 melanoma cells. Int J Cancer, 56, 867-73.
67. Himelstein BP, Canete-Soler R, Bernhard EJ, et al. 1994, Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells. J Cell Sci, 107, 477-86.
68. Baici A, Knöpfel M and Keist R, 1988, Tumor-host interactions in the rabbit V2 carcinoma: stimulation of cathepsin B in host fibroblasts by a tumor-derived cytokine. Invasion Metastasis, 8, 143-58.
69. Fabra A, Nakajima M and Bucana CD, 1992, Modulation of the invasive phenotype of human colon carcinoma cells by organ-specific fibroblasts of nude mice. Differentiation, 52, 101-10.
70. Nakajima M, Morikawa K and Fabra A, 1990, Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J Natl Cancer Inst, 82, 1890-8.
71. r 72,000 matrix metalloproteinase at cell surface invadopodia. Cancer Res, 53, 3159-64.
72. Reynolds TY, Rockwell S and Glazer PM, 1996, Genetic instability induced by the tumor microenvironment. Cancer Res, 56, 5754-7.
73. Ling V, Chambers AF, Harris JF and Hill RP, 1985, Quantitative genetic analysis of tumor progression. Cancer Metastasis Rev, 4, 173-94.
74. MacDougall JR, Bani MR, Lin Y, et al. 1995, The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res, 55, 4174-181.
75. Rao JS, Yamamoto M, Mohaman S, et al. 1996, Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas. Clin Exp Metastasis, 14, 12-18.
76. Sawaya RE, Yamamoto M, Gokaslan ZL, et al. 1996, Expression and localizaion of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin Exp Metastasis, 14, 35-42.
77. Naylor MS, Stamp GW, Davies BD, et al. 1994, Expression and activity of MMPs and their regulators in ovarian cancer. Int J Cancer, 58, 50-6.
78. r 72,000 type IV collagen and interstitial collagenase in human tumorigenic cell lines. Cancer Res, 50, 6184-91.
79. Rao VH, Bridge JA, Neff JR, et al. 1995, Expression of 72 kDa and 92 kDa type IV collagenases from human giant cell tumor of bone. Clin Exp Metastasis, 13, 420-6.
80. Sato H, Kida Y, Mai M, et al. 1992, Expression of genes encoding type IV collagen-degrading metalloproteinases in various human tumor cells. Oncogene, 7, 77-83.
81. Autio-Harmainen H, Karttunen T, Hurskainen T, et al. 1993, Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors. Lab Invest, 69, 312-21.
82. Poulsom R, Pignatelli M, Stetler-Stevenson WG, et al. 1992, Stromal expression of 72 kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol, 141, 389-96.
83. Pyke C, Ralfkiser E, Tryggvason K, et al. 1993, Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol, 142, 359-65.
84. r 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res, 52, 1336-41.